BRANDON STEWART: Open Payments
NPI 1275295925 · MONTGOMERY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 37 payments from 12 companies in 2025. Trend: 2023 $36 · 2024 $16 · 2025 $731
Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $183 |
| Madrigal Pharmaceuticals | 3 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $141 |
| QOL Medical, LLC | 4 | $73 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| TerSera Therapeutics LLC | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Olympus America Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: REZDIFFRA, RINVOQ, ENTYVIO, SKYRIZI, Sucraid, DUPIXENT, GATTEX, XIFAXAN.
Industry payments across OH — which companies pay providers there.
